Kyoto University Hospital will start clinical trials for Parkinson’s disease that transplants dopaminergic progenitors generated from induced pluripotent stem (iPS) cells.
About 5 million iPS cell-derived dopaminergic progenitors will be transplanted by stereotaxic brain surgery into the left and right sides of the patient’s putamen.
A 12mm diameter hole will be drilled on the patient’s skull, and stem cells will be injected using a specialized device.
Patient aged between 50 and 69 will participate in the trial and their progress will be monitored for two years.
About 10 million people in the world have Parkinson’s. About one million people in the USA have Parkinson’s.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.